Unraveling the Amyloid Hypothesis

This chapter addresses the fallout from a pivotal 2006 paper on Alzheimer's disease that is now under scrutiny for potential data fabrication. It explores the implications of these allegations on research integrity, drug development, and the ongoing debate surrounding the amyloid hypothesis. Furthermore, the chapter highlights the shift towards investigating alternative models, such as tau proteins, in the quest to understand and treat Alzheimer's.